Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history shows a new release entry for v3.4.3 and removes the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-11T14:24:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the record history; the funding notice and the prior Revision v3.4.1 entry were removed.
    Difference
    0.9%
    Check dated 2026-02-11T02:05:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page adds a site-wide funding notice banner. It also records a new revision (v3.4.1) in the history, replacing the previous v3.4.0.
    Difference
    0.9%
    Check dated 2026-02-03T22:53:53.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Glossary display and color-coded change indicators (green for additions, red for deletions) were added to the Record History page. The revision banner now shows Revision: v3.4.0, replacing the previous version.
    Difference
    1%
    Check dated 2026-01-27T19:56:01.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The Study Record Versions list now includes a new entry for Revision: v3.3.4, indicating a minor update to the page history rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:45:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes are administrative and do not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-22T23:56:20.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.